Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2007Proceedings of the National Academy of SciencesOpen Access

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

View Full Paper
Ask AI
Bookmark
Share

Authors

DVDanila ValmoriInstitut de Cancérologie de l'OuestNSNaira E. SouleimanianAlbert Einstein College of MedicineVTValeria ToselloIstituto Oncologico Veneto

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Valmori et al. (2007) studied this question.

synapsesocial.com/papers/6a727cc0ac440176ef2ab3b2https://doi.org/10.1073/pnas.0703395104
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer/testis antigens: an expanding family of targets for cancer immunotherapy2002 · 888 citations
  2. 2CpG-DNA aided cross-presentation of soluble antigens by dendritic cells2002 · 175 citations
  3. 3Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans2004 · 441 citations
  4. 4CpG-DNA Aided Cross-Priming by Cross-Presenting B Cells2004 · 140 citations